3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
3
Seizures
3
Sturge-Weber Syndrome
2
Nausea
2
Vomiting
1
Parasomnias
1
Pain
1
Neoplasms
1
Marijuana Abuse
1
Dysgeusia
1
Drug Resistant Epilepsy
1
Cognitive Dysfunction
1
Chemotherapy-Induced Peripheral Neuropathy
1
Cancer Pain
1
Cachexia
1
Breast Neoplasms
1
Behavior
1
Arthralgia
1
Appetitive Behavior
1
Anxiety Disorders
1
Interventions
Fentanyl
19
Analgesia
15
Acupuncture Therapy
13
Oxycodone
12
Zoledronic Acid
11
Surveys and Questionnaires
10
nabiximols
9
Therapeutics
9
Morphine
9
Acetaminophen
9
Psychiatric Rehabilitation
8
Ketamine
8
Hydromorphone
7
Lidocaine
6
Ibandronic Acid
6
Radiotherapy
5
Early Intervention, Educational
5
Bupivacaine
5
Analgesics, Opioid
5
Yoga
4
Transcutaneous Electric Nerve Stimulation
4
Therapeutic Touch
4
Ropivacaine
4
Music Therapy
4
Methadone
4
Massage
4
Aromatherapy
4
alvimopan
3
Tapentadol
3
Saline Solution
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pain
×
Cannabidiol
×
Clear all
NCT03948074
2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2
Completed
91 enrolled